Suggestions
Michael Weiner
Chairman
Michael Weiner is a prominent figure in the biotechnology and healthcare industry who leads Argosy Funds, focusing on investments in companies with disruptive technologies targeting various health conditions such as Alzheimer's, Macular Degeneration, ADHD, cancer, and heart disease.
With a strong belief in the importance of innovation in medicine, Michael Weiner criticizes the traditional healthcare system for hindering progress and causing delays in advancements, resulting in avoidable deaths and high costs.
He represents a team of medical inventors, MD's, PhD's, scientists, and engineers who have developed patented technologies for reversing Alzheimer's, Vascular Dementia, Macular Degeneration, and TBI, with the aim of bringing these solutions to market rapidly to prevent unnecessary loss of life.
Michael Weiner's educational background includes certificates from Xerox Management and Sales Training, high school education from Sheepshead Bay High School and Lincoln High, and real-world entrepreneurship studies at City University of New York-Hunter College.
Throughout his career, Michael Weiner has held leadership positions in various organizations such as being the Chairman of Argosy Holdings, CEO of NooThera Technologies, LLC, and Cofounder of several companies including Lumineu, Inc., Electrohealing Holdings, Inc., Biophan Technologies, Inc., and more.
He has also been involved in speaking engagements at prestigious events like the Conference on Future Energy, Brink Institute, and TedMed, and has sponsored events like Milken Conference, highlighting his commitment to sharing knowledge and promoting cutting-edge technologies.
With a vast and diverse professional experience ranging from software market expansion at Xerox Corporation to founding and managing multiple successful ventures, Michael Weiner brings a wealth of expertise and a visionary approach to the healthcare and biotechnology sectors.
Michael Weiner's mission is to revolutionize the medical industry by bringing life-saving technologies to market efficiently, affordably, and profitably to prevent unnecessary deaths and improve healthcare outcomes.
